New Technologies in the Management of Post-prostatectomy Urinary Incontinence

  • Neha R. Malhotra
  • Y. Zaki Almallah


In the last decade, we made great strides in the management of post-prostatectomy urinary incontinence (PPI), but the quest for the “perfect” device continues (Doherty and Almallah. BMJ 343:d6298, 2011). This chapter aims to familiarize the practicing urologist with new horizons in treatment of PPI.

Placement of an artificial urinary sphincter (AUS) has typically been recognized as the most reliable treatment for men with severe PPI. Various slings are available and have been discussed in the previous chapters, but none have shown success rates equal to that of the AUS for the treatment of severe stress incontinence. Bulking agents have shown poor efficacy and durability. Attempts have been made to engineer other mechanical devices to improve PPI, but none have gained widespread acceptance, and none are approved in the United States. Others suggest that rather than mechanical devices, tissue-based solutions will be the next treatment for PPI. Studies utilizing stem cells show promise in both animal and human models, but thus far no large studies have shown durability or efficacy.

Furthermore, as a group of urologists with special passion to help patients with PPI, we should also step back and look at the bigger picture. Emphasis should be directed toward prevention of PPI, optimizing prostate cancer management, surgical training, and techniques (including the exploration of controversial focal therapy) to reduce the burden and complications of prostate cancer therapy. Additionally, patients’ education, identification, and design of referral pathways to a specialized male incontinence clinics and prostate cancer survivor programs may represent the future model of care (Almallah and Grimsley SJ. Ther Adv Urol 7(2):69–75, 2015).


Post-prostatectomy Urinary incontinence New technology 



American Medical Systems


Adjustable transobturator male system


Artificial urinary sphincter


Post-prostatectomy incontinence


Tape mechanical occlusive device


  1. 1.
    Doherty R, Almallah Z. Urinary incontinence after treatment for prostate cancer. BMJ. 2011;343:d6298.CrossRefPubMedGoogle Scholar
  2. 2.
    Almallah YZ, Grimsley SJ. A report of a regional service for post-prostatectomy urinary incontinence: a model for best practice? Ther Adv Urol. 2015;7(2):69–75.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Seweryn J, Bauer W, Ponholzer A, et al. Initial experience and results with a new adjustable transobturator male system for the treatment of stress urinary incontinence. J Urol. 2012;187(3):956–61.CrossRefPubMedGoogle Scholar
  4. 4.
    Friedl A, Bauer W, Rom M, et al. Sexuality and erectile function after implantation of an Adjustable Transobturator Male System (ATOMS) for urinary stress incontinence. A multi-institutional prospective study. Arch Ital Urol Androl. 2015;87(4):306–11.CrossRefGoogle Scholar
  5. 5.
    Gonzalez SP, Cansino JR, Portilla MA, et al. First experience with the ATOMS((R)) implant, a new treatment option for male urinary incontinence. Cent European J Urol. 2014;67(4):387–91.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Friedl A, Zachoval P, Muhlstadt S, Giammo A, Kiravaranovic D, Rom M, Fornara P, Brossner C. Long-term outcome after implantation of the ATOMS continence device: 7 year multi-center data. Tokyo: ICS; 2016.Google Scholar
  7. 7.
    Hoda MR, Primus G, Fischereder K, et al. Early results of a European multicentre experience with a new self-anchoring adjustable transobturator system for treatment of stress urinary incontinence in men. BJU Int. 2013;111(2):296–303.CrossRefPubMedGoogle Scholar
  8. 8.
    Friedl A, Muhlstadt S, Rom M, et al. Risk factors for treatment failure with the adjustable transobturator male system incontinence device: who will succeed, who will fail? Results of a multicenter study. Urology. 2016;90:189–94.CrossRefPubMedGoogle Scholar
  9. 9.
    Knight SL, Susser J, Greenwell T, et al. A new artificial urinary sphincter with conditional occlusion for stress urinary incontinence: preliminary clinical results. Eur Urol. 2006;50(3):574–80.CrossRefPubMedGoogle Scholar
  10. 10.
    Chung E, Ranaweera M, Cartmill R. Newer and novel artificial urinary sphincters (AUS): the development of alternatives to the current AUS device. BJU Int. 2012;110(Suppl 4):5–11.CrossRefPubMedGoogle Scholar
  11. 11.
    Staerman F, Christophe G-L, Leon P, et al. ZSI 375 artificial urinary sphincter for male urinary incontinence: a preliminary study. BJU Int. 2013;111(4 Pt B):E202–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Kretschmer A, Husch T, Thomsen F, et al. Efficacy and safety of the ZSI375 artificial urinary sphincter for male stress urinary incontinence: lessons learned. World J Urol. 2016;34(10):1457–63.CrossRefPubMedGoogle Scholar
  13. 13.
    Malaeb BS, Elliott SP, Lee J, et al. Novel artificial urinary sphincter in the canine model: the tape mechanical occlusive device. Urology. 2011;77(1):211–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Tran C, Damaser MS. The potential role of stem cells in the treatment of urinary incontinence. Ther Adv Urol. 2015;7(1):22–40.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Fu Q, Song XF, Liao GL, et al. Myoblasts differentiated from adipose-derived stem cells to treat stress urinary incontinence. Urology. 2010;75(3):718–23.CrossRefPubMedGoogle Scholar
  16. 16.
    Lin G, Wang G, Banie L, et al. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy. 2010;12(1):88–95.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Zhang Y, McNeill E, Tian H, et al. Urine derived cells are a potential source for urological tissue reconstruction. J Urol. 2008;180(5):2226–33.CrossRefPubMedGoogle Scholar
  18. 18.
    Carr LK, Robert M, Kultgen PL, et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol. 2013;189(2):595–601.CrossRefPubMedGoogle Scholar
  19. 19.
    Gotoh M, Yamamoto T, Kato M, et al. Regenerative treatment of male stress urinary incontinence by periurethral injection of autologous adipose-derived regenerative cells: 1-year outcomes in 11 patients. Int J Urol. 2014;21(3):294–300.CrossRefPubMedGoogle Scholar
  20. 20.
    Lehur PA, Wyart V, Riche VP. SaFaRI: sacral nerve stimulation versus the Fenix(R) magnetic sphincter augmentation for adult faecal incontinence: a randomised investigation. Int J Color Dis. 2016;31(8):1505.CrossRefGoogle Scholar
  21. 21.
    Williams AE, Croft J, Napp V, et al. SaFaRI: sacral nerve stimulation versus the FENIX magnetic sphincter augmentation for adult faecal incontinence: a randomised investigation. Int J Color Dis. 2016;31(2):465–72.CrossRefGoogle Scholar
  22. 22.
    Wong MT, Meurette G, Stangherlin P, et al. The magnetic anal sphincter versus the artificial bowel sphincter: a comparison of 2 treatments for fecal incontinence. Dis Colon Rectum. 2011;54(7):773–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Barussaud ML, Mantoo S, Wyart V, et al. The magnetic anal sphincter in faecal incontinence: is initial success sustained over time? Color Dis. 2013;15(12):1499–503.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of UrologyUniversity of Illinois at ChicagoChicagoUSA

Personalised recommendations